Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report) shares crossed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of C$7.32 and traded as low as C$7.10. Eupraxia Pharmaceuticals shares last traded at C$7.25, with a volume of 1,015,479 shares.
Eupraxia Pharmaceuticals Stock Performance
The stock has a fifty day moving average price of C$7.54 and a 200 day moving average price of C$7.32.
About Eupraxia Pharmaceuticals
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing locally administered therapies for inflammatory and fibrotic diseases. The company’s programs are designed to deliver active pharmaceutical ingredients directly to affected tissues while potentially limiting systemic exposure and associated side effects.
Eupraxia’s development platform uses a proprietary diffusion-based hydrogel technology intended to provide controlled, sustained drug release.
Featured Articles
- Five stocks we like better than Eupraxia Pharmaceuticals
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Eupraxia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eupraxia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
